Lilly recommits to Alzheimer’s efforts (The Indianapolis Star)
Wednesday, December 23rd, 2009Vernon Hills, Ill. — Illinois-based biotechnology developer Applied NeuroSolutions and Indianapolis-based drug maker Eli Lilly and Co. announced Tuesday they’ll continue to collaborate on the development of products for the early diagnosis and treatment of Alzheimer’s disease. Applied NeuroSolutions will receive $750,000 from Lilly and later may get up to ... continue reading